These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25563595)

  • 21. Use of the European Organisation for Research and Treatment of Cancer multiple myeloma module (EORTC QLQ-MY20): a review of the literature 25 years after development.
    Forde K; Cocks K; Wells JR; McMillan I; Kyriakou C;
    Blood Cancer J; 2023 May; 13(1):79. PubMed ID: 37193682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life and use of medication with anticholinergic activity in patients with multiple myeloma.
    de Lima MSR; de Pádua CAM; de Miranda Drummond PL; Silveira LP; Malta JS; Dos Santos RMM; Reis AMM
    Support Care Cancer; 2023 Jun; 31(7):379. PubMed ID: 37278732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
    Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
    Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer.
    Tomaszewski KA; Püsküllüoğlu M; Biesiada K; Bochenek J; Nieckula J; Krzemieniecki K
    J Psychosoc Oncol; 2013; 31(2):191-203. PubMed ID: 23514254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer.
    Paradowski J; Tomaszewski KA; Bereza K; Tomaszewska IM; Pasternak A; Paradowska D; Szczęsny E; Golec EB; Greimel ER; Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):157-63. PubMed ID: 24354727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma.
    Chmielowska K; Tomaszewski KA; Pogrzebielski A; Brandberg Y; Romanowska-Dixon B
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):88-96. PubMed ID: 22966840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of Life in Brain Cancer: Clinical Validation of the Mexican-Spanish Version of the EORTC QLQ-BN20 Questionnaire.
    Cacho-Díaz B; Lorenzana-Mendoza NA; Oñate-Ocaña LF
    Front Neurol; 2019; 10():40. PubMed ID: 30761074
    [No Abstract]   [Full Text] [Related]  

  • 31. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary psychometric validation of the Polish version of the EORTC elderly module (QLQ-ELD14).
    Wrazen W; Golec EB; Tomaszewska IM; Walocha E; Dudkiewicz Z; Tomaszewski KA
    Folia Med Cracov; 2014; 54(2):35-45. PubMed ID: 25648308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric properties of the Chilean version of the quality of life questionnaire for multiple myeloma.
    Lorca LA; Sacomori C; Peña C; Barrera C; Salazar M; Leão I; Valladares X; Rojas C
    Rev Bras Enferm; 2024; 77(1):e20230100. PubMed ID: 38716906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-Related Quality of Life and Satisfaction With Health Care: Relation to Clinical Stage in Mexican Patients With Multiple Myeloma.
    Balderas-Peña LM; Miranda-Ruvalcaba C; Robles-Espinoza AI; Sat-Muñoz D; Ruiz MG; García-Luna E; Nava-Zavala AH; Rubio-Jurado B
    Cancer Control; 2019; 26(1):1073274819831281. PubMed ID: 30786721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients.
    Arraras JI; Arias F; Tejedor M; Pruja E; Marcos M; Martínez E; Valerdi J
    Psychooncology; 2002; 11(3):249-56. PubMed ID: 12112486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Validation of an instrument to measure life quality in breast cancer patients].
    Fernández-Suárez HG; Blum-Grynberg B; Aguilar-Villalobos EJ; Bautista-Rodríguez H
    Rev Med Inst Mex Seguro Soc; 2010; 48(2):133-8. PubMed ID: 20929615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations.
    Awad MA; Denic S; El Taji H
    Ann N Y Acad Sci; 2008 Sep; 1138():146-54. PubMed ID: 18837895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary validation of the IOF QLQ and comparison with the SF-36 in patients after a distal radius fracture.
    Bonczar T; Rutowicz B; Mizia E; Depukat P; Walocha E; Pelka P; Tomaszewski KA; Walocha JA
    Folia Med Cracov; 2014; 54(4):35-44. PubMed ID: 25891241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.